Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anthrasil PK and Safety Study
NCT00845650Phase 2Completed
- Sponsor
- Emergent BioSolutions
- Start
- Feb 2009
- Primary completion
- Oct 2010
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of anthrax immune globulin human in anthrax, sponsored by Emergent BioSolutions. Started Feb 2009; status: completed.
02
Drugs
anthrax immune globulin human
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT00845650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845650.